Reports

Ideas That Generate Results

Glenmark Pharmaceuticals Ltd. - Company Analysis

Glenmark Pharmaceuticals Ltd. - Company Analysis

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Mar, 2011| No. of Pages : 30

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 150.00
CD-ROM Mail Delivery
US$ 200.00
Hard Copy Mail Delivery
US$ 200.00
Electronic Access - Multi-User License
US$ 300.00

List of Figures:

Figure 2-1: Glenmark Pharmaceuticals Ltd. - Revenue by Geographical Distribution (%), FY 2010
Figure 2-2: Glenmark Pharmaceuticals Ltd. - Revenue by Business Segment (%), FY 2010
Figure 3-1: Glenmark Pharmaceuticals Ltd. - Stock Chart

List of Tables:

Table 1-1: Glenmark Pharmaceuticals Ltd. - Ticker Codes at Various Stock Exchanges
Table 1-2: Glenmark Pharmaceuticals Ltd. - Major Mergers & Acquisitions (2005 & 2008)
Table 1-3: Glenmark Pharmaceuticals Ltd. - Key Management People
Table 3-1: Glenmark Pharmaceuticals Ltd. - Financial Overview (Million US$), FY 2010
Table 3-2: Glenmark Pharmaceuticals Ltd. - Breakup of Revenue & Sales (Million US$), FY 2008 to FY 2010
Table 3-3: Glenmark Pharmaceuticals Ltd. - Key Financial Ratios (FY 2008 to FY 2010)
Table 3-4: Glenmark Pharmaceuticals Ltd. - Earning & Income Estimates (Million US$), FY 2008 to FY 2010
Table 5-1: Lupin Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-2: Lupin Limited - SWOT Analysis
Table 5-3: Dr. Reddy's Laboratories Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-4: Dr. Reddy's Laboratories Limited - SWOT Analysis
Table 5-5: Wockhardt Limited - Key Financials (Million US$), FY 2008 to FY 2010
Table 5-6: Wockhardt Limited - SWOT Analysis

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.